Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-J Body

Showing results (201-210 of 213) with videos related to

Pageof 22
Sort By:
British Journal of Cancer|November 8, 2012
Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastasesB Beuselinck, P Wolter, A Karadimou, et al.
Bone|March 14, 2026
Bone strain index improves 10-year fracture risk prediction beyond bone mineral density and FRAX® in community-dwelling older women: A study of the FRISBEE cohortJ de Filette, A Bellanger, L Rinaudo, et al.
European Journal of Endocrinology|September 22, 2014
The PRIMARA study: a prospective, descriptive, observational study to review cinacalcet use in patients with primary hyperparathyroidism in clinical practiceP Schwarz, J J Body, J Cáp, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 1999
Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancyR Rizzoli, D Thiébaud, N Bundred, et al.
Rehabilitacion|September 20, 2025
Associations between bone mineral density loss in the past decade and sarcopenia in community-dwelling older women-The FRISBEE 2 studyA Bellanger, D Sanchez-Rodriguez, F K Youssa Nzintcheu, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 12, 2026
Non-metastatic breast cancer patients discontinuing aromatase inhibitor on denosumab: what next?G Marcucci, E Biver, J J Body, et al.
Journal of Bone Oncology|May 17, 2021
Osteoporosis management in hematologic stem cell transplant recipients: Executive summaryD L Kendler, J J Body, M L Brandi, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 5, 2018
Bone management in hematologic stem cell transplant recipientsD L Kendler, J J Body, M L Brandi, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 23, 2007
Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosisJ P Devogelaer, J P Brown, P Burckhardt, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 31, 2016
The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone ClubE Cavalier, P Bergmann, O Bruyère, et al.
Pageof 22

Showing results (201-210 of 213) with videos related to

Sort By:
Pageof 22
British Journal of Cancer|November 8, 2012
Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastasesB Beuselinck, P Wolter, A Karadimou, et al.
Bone|March 14, 2026
Bone strain index improves 10-year fracture risk prediction beyond bone mineral density and FRAX® in community-dwelling older women: A study of the FRISBEE cohortJ de Filette, A Bellanger, L Rinaudo, et al.
European Journal of Endocrinology|September 22, 2014
The PRIMARA study: a prospective, descriptive, observational study to review cinacalcet use in patients with primary hyperparathyroidism in clinical practiceP Schwarz, J J Body, J Cáp, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 1999
Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancyR Rizzoli, D Thiébaud, N Bundred, et al.
Rehabilitacion|September 20, 2025
Associations between bone mineral density loss in the past decade and sarcopenia in community-dwelling older women-The FRISBEE 2 studyA Bellanger, D Sanchez-Rodriguez, F K Youssa Nzintcheu, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 12, 2026
Non-metastatic breast cancer patients discontinuing aromatase inhibitor on denosumab: what next?G Marcucci, E Biver, J J Body, et al.
Journal of Bone Oncology|May 17, 2021
Osteoporosis management in hematologic stem cell transplant recipients: Executive summaryD L Kendler, J J Body, M L Brandi, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 5, 2018
Bone management in hematologic stem cell transplant recipientsD L Kendler, J J Body, M L Brandi, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 23, 2007
Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosisJ P Devogelaer, J P Brown, P Burckhardt, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 31, 2016
The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone ClubE Cavalier, P Bergmann, O Bruyère, et al.
Pageof 22